| 000 | 01782 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515211936.0 | ||
| 264 | 0 | _c20100827 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1097-4644 | ||
| 024 | 7 |
_a10.1002/jcb.22538 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJurado, Susana | |
| 245 | 0 | 0 |
_aEffect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. _h[electronic resource] |
| 260 |
_bJournal of cellular biochemistry _cMay 2010 |
||
| 300 |
_a304-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDinoprostone _xpharmacology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1beta _xpharmacology |
| 650 | 0 | 4 |
_aOsteoblasts _xcytology |
| 650 | 0 | 4 |
_aOsteoporosis _xgenetics |
| 650 | 0 | 4 |
_aOsteoprotegerin _xgenetics |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aRANK Ligand _xgenetics |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xpharmacology |
| 700 | 1 | _aGarcia-Giralt, Natalia | |
| 700 | 1 | _aDíez-Pérez, Adolfo | |
| 700 | 1 | _aEsbrit, Pedro | |
| 700 | 1 | _aYoskovitz, Guy | |
| 700 | 1 | _aAgueda, Lídia | |
| 700 | 1 | _aUrreizti, Roser | |
| 700 | 1 | _aPérez-Edo, Lluís | |
| 700 | 1 | _aSaló, Guillem | |
| 700 | 1 | _aMellibovsky, Leonardo | |
| 700 | 1 | _aBalcells, Susana | |
| 700 | 1 | _aGrinberg, Daniel | |
| 700 | 1 | _aNogués, Xavier | |
| 773 | 0 |
_tJournal of cellular biochemistry _gvol. 110 _gno. 2 _gp. 304-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcb.22538 _zAvailable from publisher's website |
| 999 |
_c19591486 _d19591486 |
||